News
StockStory.org on MSN18h
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has ...
StockStory.org on MSN1d
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers StocksThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Cigna Group's CI -0.26% + Free Alerts short percent of float has fallen 14.19% since its last report. The company recently ...
Chewy topped Q1 expectations with $3.12 billion in sales and 35 cents EPS, driven by subscription growth and rising customer ...
CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...
Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...
Senate Republicans are plotting deeper Medicaid cuts to bankroll tax reforms, ditching previous plans to trim Medicare ...
Cigna Group’s stock had a strong session, closing at $314.31 after a $4.11 surge that turned investor heads. The stock jumped 1.32% for the day, riding a wave of optimism and charting a course well ...
Earnings per share of $0.07, beating the estimated $0.03, showcasing stronger-than-expected profitability. Revenue of ...
Financials are currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results